ETFsXtrackers II Target Maturity Sept 2031 EUR Corporate Bond UCITS ETF 1D
Xtrackers

Xtrackers II Target Maturity Sept 2031 EUR Corporate Bond UCITS ETF 1D

LU2673523481 EUFUNDDistributingLuxembourg
Last close · EUR
29.34EUR
+0.14% · +€0.04
Published closes: 1 Oct 2026 - 2 Oct 2026
2 Oct 2026, close
LU2673523481Base
Fund charges
Not publishedFee basis unverified
Fund size
Not published
Return 1Y
-2.7%
Sharpe 3Y
Not published
Volatility 1Y
3.3%annualised
Holdings
326Fund holdings

Performance

Compare
  • LU2673523481-2.7%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
LU2673523481-0.6%-2.6%-1.2%-2.4%-2.7%--
MSCI World+2.6%+3.8%+17.8%+16.3%+20.0%+68.3%+81.8%
Gap to MSCI World-3.2%-6.4%-19.0%-18.7%-22.7%--

Risk and return

Sharpe ratio · 1Y
-1.41
Below MSCI World · 1.28
Return p.a.
-2.7%
Volatility
3.3%
Max loss
-4.2%Sept 2026

Sharpe vs indices

MSCI World
1.28
S&P 500
1.16
STOXX Europe 600
0.99
MSCI Emerging Markets IMI
0.76
CAC 40
-0.01
LU2673523481
-1.41
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
6.5%
Holdings
326
As of
Fund holdings
  1. 1THERMO FISHER SCIENTIFIC (FINAN)XS23664070180.75%
  2. 2DH EUROPE FINANCE II SARLXS20504060940.72%
  3. 3CREDIT AGRICOLE SAFR001400HCR40.70%
  4. 4TAKEDA PHARMACEUTICAL CO LTDXS18434493950.69%
  5. 5ING GROEP NVXS19091864510.67%
  6. 6SIEMENS FINANCIERINGSMAATSCHAPPIJXS25897901090.60%
  7. 7VERIZON COMMUNICATIONS INCXS25508811430.59%
  8. 8STELLANTIS NVXS26346901140.58%
  9. 9BANQUE FEDERATIVE DU CREDIT MUTUELFR0014014TL20.57%
  10. 10CAPGEMINI SEFR0014012S970.57%

Countries

Classified 100.0%
Largest
26.1%United States
Top 3
57.2%
Effective number
7.41 / HHI

Market cap

Weight vs holdings

6.5%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-200
  • Holdings 201+

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.